Keep away from concomitant usage of tucatinib with CYP3A substrates, where by small focus changes may bring on major or lifestyle-threatening toxicities. If unavoidable, cut down CYP3A substrate dose Based on solution labeling.phenobarbital will minimize the extent or result of diazepam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use